ľֱ

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

— News, features, and commentary about cancer-related issues

Last Updated September 13, 2024
MedpageToday
Onco Break over a computer rendering of a cancer cell.

Rates of still have not returned to expected levels following COVID-related disruptions. (University of Kentucky, JAMA Network Open)

The FDA for all the adult indications the IV version of atezolizumab (Tecentriq) carries, including small cell and non-small cell lung cancer, liver cancer, melanoma, and alveolar soft part sarcoma.

A new cancer diagnosis may affect the of patients' family members. (Cancer)

In laboratory studies, a drug that inhibits cholesterol production has shown the ability to kill cells and inhibit tumor angiogenesis. (University of Missouri, Journal of the Endocrine Society)

A researcher created a novel delivery system for drugs that may help reduce the associated with cisplatin-containing chemotherapy. (University of Oklahoma Health Sciences, Journal of Nanobiotechnology)

Major League Baseball Hall of Famer said he is receiving treatment for prostate cancer. (ESPN)

A 19-year-old man's perplexing case of lung cancer led to the discovery of a that affects younger people with no history of smoking. (Memorial Sloan Kettering Cancer Center, Cancer Discovery)

A has eliminated up to 99% of cancer cells in laboratory studies. (Aston University)

A former breast cancer researcher and used images from another scientist without attribution, according to from the U.S. Office of Research Integrity. The paper was retracted in March. (Retraction Watch)

Drugmaker AbbVie sued rival BeiGene for allegedly about a new drug's development after hiring an AbbVie scientist. (Reuters)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined ľֱ in 2007.